NEUP Neuphoria Therapeutics Inc.

NASDAQ
$3.65

Neuphoria Therapeutics Inc. (NEUP) is expected to report earnings on December 18, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -1.7% since its last earnings release on September 18, 2026.

Neuphoria Therapeutics Beat Consensus Estimates
Friday, September 18, 2026 · 12:00 AM ET
Earnings Date
1st Quarter, Sep 2026
Dec 18
Friday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.70

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Neuphoria Therapeutics Inc.

Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.